Overview
Southern Symposium on Heart Failure
Online registration is no longer available for the Southern Symposium on Heart Failure. You will be able to register in-person onsite the day of the symposium.
This live, one-day symposium will offer updates and detailed insights into heart failure and treatment options. Through focused didactics, panel discussions, and interactive dialogue, participants will gain both broad perspectives and detailed insights on the following topics:
• Impact of recent clinical trials on the treatment of heart failure
• Types of primary cardiomyopathies and methods for diagnosis
• Recent advances in short-term support for treatment of cardiogenic shock
• Co-management of heart failure between EP and the heart failure team
• Advanced therapies for heart failure including transplant and mechanical circulatory support
• Transitioning VAD patients back to the community and their care providers
• Role of palliative care for patients with end-stage heart failure
• Establishing a community-based disease management practice for heart failure
This activity is intended for cardiologists, primary care physicians, advanced practice providers, registered nurses, allied health professionals, and residents/fellows involved in the diagnosis and treatment of heart failure.
The purpose of this CME/CE conference is to educate clinicians on the current management of heart failure and emerging therapies that may impact treatment paradigms and patient outcomes. As more research in the field of heart failure gives rise to the emergence of new treatment options, it is critical that clinicians be up to date on the currently available treatments, emerging treatments, and the safety and effectiveness data.
Upon completion of this activity, participants will be able to:
• Discuss Medicare/Medicaid quality improvement programs and measures and their relationship with evidence-based guideline recommendations for heart failure (HF).
• Evaluate current clinical practice guidelines/clinical trials surrounding optimal pharmacological management of HF.
• Compare and contrast legacy practice paradigms surrounding heart failure with emerging evidence-based protocols designed to reduce HF-related complications and re-hospitalizations.
• Evaluate the role of device-based interventions and surgical approaches in the care of heart failure, especially for refractory cases.
• Develop customized, targeted HF treatment strategies that consider a variety of patient populations, disease severity/subclasses, comorbidities, phenotypes, and/or individual treatment responses.
• Discuss socioeconomic, geographic, racial/ethnic, and gender-based variables that may contribute to worse HF outcomes in the context of targeted HF treatment strategies.
• Discuss Medicare/Medicaid quality improvement programs and measures and their relationship with evidence-based guideline recommendations for heart failure (HF).
• Evaluate current clinical practice guidelines/clinical trials surrounding optimal pharmacological management of HF.
• Compare and contrast legacy practice paradigms surrounding heart failure with emerging evidence-based protocols designed to reduce HF-related complications and re-hospitalizations.
• Evaluate the role of device-based interventions and surgical approaches in the care of heart failure, especially for refractory cases.
• Develop customized, targeted HF treatment strategies that consider a variety of patient populations, disease severity/subclasses, comorbidities, phenotypes, and/or individual treatment responses.
• Discuss socioeconomic, geographic, racial/ethnic, and gender-based variables that may contribute to worse HF outcomes in the context of targeted HF treatment strategies.
Emory Saint Joseph's Hospital
Ground Floor Auditorium
5665 Peachtree Dunwoody Road, NE
Atlanta, GA 30342 USA
Click here to view location map
Ground Floor Auditorium
5665 Peachtree Dunwoody Road, NE
Atlanta, GA 30342 USA
Click here to view location map
7:30 AM – 8:00 AM: Registration and Breakfast
8:00 AM: Welcome
8:15 AM: Keynote Address: Ventricular Assist Devices: Latest Advances to Optimize Clinical Use
9:00 AM: Crashing and Burning: Cardiogenic Shock and Short-Term Mechanical Circulatory Support
9:30 AM: Can Implantable Cardiac Rhythm Management Devices and Remote Monitoring Devices Help My Heart Failure Patients? Optimizing Patient Selection
10:00 AM: Break
10:15 AM: Keynote Address: What’s New in Heart Failure Clinical Studies – Breaking Trials
11:00 AM: Current Issues in Transplantation: Higher Risk Recipients, Donors with Hep C and Bridging ECMO
11:30 AM: It’s All About the Right Ventricle: Imaging Modalities, Risk Stratification, and Short-Term Support
12:00 PM: Lunch
12:45 PM: Breakout Session 1: Dr. Google: When Your Patient Asks About “Alternative” Treatments for Heart Failure
12:45 PM: Breakout Session 2: Approaches to Challenging Patients: Case Studies
1:30 PM: Bridging the Gap: Reducing Readmissions for Complicated Heart Failure Patients
2:00 PM: Infiltrative Cardiomyopathies and the Newest Treatments for Amyloidosis
2:30 PM: Break
2:45 PM: Palliative Care as Part of the Heart Failure Treatment Plan
3:15 PM: Updates in Adult Congenital Heart Disease
3:45 PM: When Treatment Is Toxic to the Heart: Preventing Heart Failure in Cancer Survivors
4:15 PM: Closing Remarks, Evaluations and Adjournment
8:00 AM: Welcome
8:15 AM: Keynote Address: Ventricular Assist Devices: Latest Advances to Optimize Clinical Use
9:00 AM: Crashing and Burning: Cardiogenic Shock and Short-Term Mechanical Circulatory Support
9:30 AM: Can Implantable Cardiac Rhythm Management Devices and Remote Monitoring Devices Help My Heart Failure Patients? Optimizing Patient Selection
10:00 AM: Break
10:15 AM: Keynote Address: What’s New in Heart Failure Clinical Studies – Breaking Trials
11:00 AM: Current Issues in Transplantation: Higher Risk Recipients, Donors with Hep C and Bridging ECMO
11:30 AM: It’s All About the Right Ventricle: Imaging Modalities, Risk Stratification, and Short-Term Support
12:00 PM: Lunch
12:45 PM: Breakout Session 1: Dr. Google: When Your Patient Asks About “Alternative” Treatments for Heart Failure
12:45 PM: Breakout Session 2: Approaches to Challenging Patients: Case Studies
1:30 PM: Bridging the Gap: Reducing Readmissions for Complicated Heart Failure Patients
2:00 PM: Infiltrative Cardiomyopathies and the Newest Treatments for Amyloidosis
2:30 PM: Break
2:45 PM: Palliative Care as Part of the Heart Failure Treatment Plan
3:15 PM: Updates in Adult Congenital Heart Disease
3:45 PM: When Treatment Is Toxic to the Heart: Preventing Heart Failure in Cancer Survivors
4:15 PM: Closing Remarks, Evaluations and Adjournment
This activity is sponsored by the Academy for Continued Healthcare Learning and Emory St. Joseph's Hospital.
Supported by educational grants from Abbott, Abiomed, Boston Scientific, Medtronic, Novartis, and Soleo Health.
| Registration Type | Early Pricing | After October 1, 2018 |
| Physicians | $150 | $175 |
| RN/NP/PA/Non-Physician Professionals/Others | $50 | $75 |
| Residents/Fellows/Medical Students | $50 | $75 |
| Industry Professionals | $150 | $175 |
David W. Markham, MD, MSc
Medical Director
Advanced Heart Failure Center
Emory Saint Joseph’s Hospital
Associate Professor
Emory University School of Medicine
Medical Director
Advanced Heart Failure Center
Emory Saint Joseph’s Hospital
Associate Professor
Emory University School of Medicine
Jeffrey S. Miller, MD
Surgical Director, Advanced Heart Failure
Heart Transplant and Mechanical Circulatory Support Program
Emory Saint Joseph's Hospital
Assistant Professor of Surgery
Emory University School of Medicine
Heart Transplant and Mechanical Circulatory Support Program
Emory Saint Joseph's Hospital
Assistant Professor of Surgery
Emory University School of Medicine
Salpy V. Pamboukian, MD, MSPH
Professor of Medicine
Director of Inpatient Services, Department of Medicine
Fellowship Director, Advanced Heart Failure and Transplant Cardiology
Director, Mechanical Circulatory Support Device Program
Co-section Head, Advanced Heart Failure, Cardiac Transplantation, Mechanical Circulatory Support, and Pulmonary Vascular Disease
University of Alabama at Birmingham
Professor of Medicine
Director of Inpatient Services, Department of Medicine
Fellowship Director, Advanced Heart Failure and Transplant Cardiology
Director, Mechanical Circulatory Support Device Program
Co-section Head, Advanced Heart Failure, Cardiac Transplantation, Mechanical Circulatory Support, and Pulmonary Vascular Disease
University of Alabama at Birmingham
Mark Slaughter, MD
Professor and Chair, Department of Cardiovascular and Thoracic Surgery
Executive Medical Director, Jewish Hospital
Director, Heart Transplant and Mechanical Assist Device Program
University of Louisville, Jewish Hospital and St. Mary’s Healthcare System
Daniel Bell, MD
Assistant Professor
Emory University School of Medicine
Kunal Bhatt, MD
Assistant Professor
Emory University School of Medicine
Kunal Bhatt, MD
Assistant Professor of Medicine
Emory University School of Medicine
Center for Advanced Heart Failure and Transplantation
Emory University Hospital
Wendy Book, MD
Professor of Medicine
Emory University School of Medicine
Director, Emory Adult Congenital Heart Center
Emory University Hospital
Alisa Frank, RN, BSN
Unit Director/VAD Coordinator
Advanced Heart Failure Center
Emory Saint Joseph's Hospital
Wendy Book, MD
Professor of Medicine
Emory University School of Medicine
Director, Emory Adult Congenital Heart Center
Emory University Hospital
Alisa Frank, RN, BSN
Unit Director/VAD Coordinator
Advanced Heart Failure Center
Emory Saint Joseph's Hospital
Divya Gupta, MD
Assistant Professor of Medicine
Emory University School of Medicine
Center for Heart Failure Therapy and Transplantation
Emory University Hospital
Sonjoy Raja Laskar, MD
Associate Professor
Emory University School of Medicine
Medical Director
Mechanical Circulatory Support Program Emory University Hospital
Sonjoy Raja Laskar, MD
Associate Professor
Emory University School of Medicine
Medical Director
Mechanical Circulatory Support Program Emory University Hospital
Anshul Patel, MD
Assistant Professor of Medicine
Emory University School of Medicine
Director of Emory Arrhythmia Center
Emory St. Joseph's Hospital
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME activity.
To receive credit, participants are required to participate in the live activity and complete an evaluation from and submit on-site. A certificate will be emailed to participants within 6 weeks.
Inquiries may be directed to ACHL at (877) 444-8435, ext. 113.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.
